12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.
Bingfeng HanWu LiuJuan DuHanyu LiuTianshuo ZhaoShubo YangShuai WangSihui ZhangBei LiuYaqiong LiuFuqiang CuiPublished in: Vaccines (2021)
At 12 months, immune response in diabetic patients were not significantly different from that in healthy people. Revaccination with one dose of hepatitis B vaccine containing 60 μg HBsAg for non-responders was more satisfactory.